Fetal tracheal balloon procedure to help lungs grow in severe congenital diaphragmatic hernia
Official title: Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Right and Left Congenital Diaphragmatic Hernia (CDH)
Run by University of Colorado, Denver · NCT03674372 · Data updated 2026-11-12
This will try a temporary tracheal balloon (FETO) in pregnant women carrying a fetus with severe left or right congenital diaphragmatic hernia to see if it helps the lungs grow and is safe.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 10 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | November 16, 2018 |
| Main results expected | March 2030 |
| Study ends | March 2030 |
| Registry record updated | June 10, 2025 |
| Trial ID | NCT03674372 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women aged 18 or older with a singleton fetus diagnosed with isolated left or right CDH with liver-up, normal fetal karyotype, and severe pulmonary hypoplasia (L-sided O/E LHR <25% or R-sided O/E LHR <45%) enrolled before 29 weeks 6 days are the intended candidates.
✕Probably not a fit
Pregnancies with milder CDH, chromosomal abnormalities, multiple gestation, advanced gestational age beyond the enrollment window, or maternal contraindications to fetoscopy are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional protocol places a balloon in the fetal trachea via fetoscopy to block airway egress and stimulate lung growth, with a second procedure to remove the device before birth. Eligibility focuses on singleton pregnancies with isolated left or right CDH, liver-up, normal karyotype, and severe pulmonary hypoplasia defined by O/E LHR thresholds, enrolled before 29 weeks and 6 days gestation. The team monitors the pregnancy while the balloon remains in place and performs planned balloon release and postnatal follow-up including neonatal respiratory support as needed. The goal is to increase lung volume prenatally so newborns have improved lung function and survival after delivery.
Why it matters
Potential benefit: If successful, fetal tracheal occlusion could increase lung growth before birth and improve newborn survival and respiratory outcomes.
How similar studies have gone: Prior case series and multicenter trials of FETO have shown increased fetal lung growth and improved survival for selected severe CDH cases, though outcomes and risks vary across studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women age 18 years and older, who are able to consent * Singleton pregnancy Fetal * Normal Karyotype * Fetal Diagnosis of Isolated Left or Right CDH with liver up * Gestation at enrollment prior to 29 wks plus 6 days * SEVERE pulmonary hypoplasia with Ultra Sound L-sided O/E LHR \< 25% or R-sided O/E LHR \<45% Exclusion Criteria: * Pregnant women \<18 years of age. * Maternal contraindication to fetoscopic surgery or severe maternal medical condition in pregnancy * Technical limitations precluding fetoscopic surgery * Rubber latex allergy * Preterm labor, cervix shortened (\<15 mm at enrollment or within 24 hours of FETO balloon insertion procedure) or uterine anomaly strongly predisposing to preterm labor, placenta previa * Psychosocial ineligibility, precluding consent * Inability to remain at FETO site during time period of tracheal occlusion, delivery and postnatal care
Where it's running
-
Children's Hospital Colorado
Aurora, Colorado, United States Recruiting
Study contacts
- Study coordinator: Elizabeth Torres
- Email: elizabeth.torres@childrenscolorado.org
- Phone: 720-777-1661
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Melatonin plus inhaled nitric oxide for pulmonary hypertension in full-term newborns
This study tests whether adding melatonin to inhaled nitric oxide helps treat pulmonary hypertension in full-term neonates.
-
FETO with a Goldballoon device for fetuses with diaphragmatic hernia
This study tests whether performing Fetoscopic Endoluminal Tracheal Occlusion on pregnancies with fetal diaphragmatic hernia improves baby survival and reduces long-term problems.
-
Fetal tracheal occlusion (FETO) for severe congenital diaphragmatic hernia
This trial will test whether fetal endoluminal tracheal occlusion (FETO) helps fetuses with severe congenital diaphragmatic hernia and intrathoracic liver herniation survive to hospital discharge.
-
Long-term outcomes after FETO for severe left or right congenital diaphragmatic hernia
This trial will test whether performing FETO in fetuses with isolated severe left or right CDH helps more babies survive to hospital discharge and have fewer long-term problems than standard care.
-
Fetal treatment for congenital diaphragmatic hernia
This study is testing a new way to treat congenital diaphragmatic hernia in unborn babies by placing a balloon in their airway to help their lungs grow before they are born.
-
Fetoscopic balloon (FETO) for severe left and right congenital diaphragmatic hernia — long-term outcomes
This trial will try placing and later removing a tiny balloon in the fetal windpipe around 27–29 weeks to help babies with severe congenital diaphragmatic hernia and liver herniation survive the newborn period.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.